Cell surface and intracellular staining was performed as previously described (15 (link), 47 (link)). Antibodies used: anti-CD3 Bv650 (OKT3, Biolegend), anti-CD3 FITC (SK7, BD Biosciences), anti-Vα7.2 PE (3C10, Biolegend), anti-CD161 Pe-Cy5 (DX12, BD Biosciences), anti-CD4 Bv711 (OKT4, Biolegend), anti-CD8 Bv570 (RPA-T8, Biolegend), anti-CD69 BUV737 (FN50, BD Biosciences), anti-CD107a BUV395 (H4A3, BD Biosciences), anti-GzB FITC (GB11, Biolegend), anti-IFNγ APC (25723.11, BD Biosciences), anti-TNF PE-Cy7 (Mab11, BD Biosciences), anti-IL17A Bv421 (BL168, Biolegend), anti-RORγt APC (R&D system), anti-RORγt Bv650 (Q21–559, BD Biosciences), anti-PLZF PECF594 (R17–809, BD Biosciences), anti-T-bet Bv711 or Bv605 (4B10, Biolegend), anti-MR1 (26.5, Biolegend), anti-HLA-DR (L243, Biolegend), anti-HLA-A2 (BB7.2, Biorad), LIVE/DEAD Fixable Aqua and Near-IR dye (Invitrogen). Flow cytometry data was acquired on BD LSRFortessa or BD Symphony A5 instruments (both BD Biosciences) and analyzed using FlowJo software v. 10.5.3 (TreeStar). Analyses of MAIT cell polyfunctionality were performed using the SPICE software v. 6.0 (48 (link)).